At ASCO 2025, several promising studies in pancreatic ductal adenocarcinoma (PDAC) were presented. In the neoadjuvant setting, the CASSANDRA trial compared the PAXG (nab-paclitaxel, capecitabine, ...

Main pancreatic duct (MPD) dilation without an apparent obstructing lesion is an independent risk factor for neoplastic ...

Oncolytics (ONCY) announced alignment with the FDA regarding the design of its pivotal study of pelareorep in combination with standard-of-care ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

During a routine mammogram, doctors found something unusual in Patty Schone’s left breast. But the real danger was actually ...

DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...

NUS Medicine-led study shows extracellular vesicles carrying gene-targeting antisense oligonucleotides (ASOs) and immune ...

However, the researchers are not saying that gallstones directly cause pancreatic cancer. Instead, they believe that ...

And, in a charming video which tells their individual stories for the Boobee Campaign - which educates women about cancer, ...

Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030 ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...